Filing metadata

Accession number
0001209191-20-060295
Form type
Form 3
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Nov 24, 2020
Reporting period
Nov 22, 2020
Description
Initial ownership

Explore SEC Filings Hub